It has been suggested that, owing to the impact of IL-6 on hepatocytes, IL-6 may function in activating PLP phosphatase activity, thus decreasing circulating PLP concentrations (McCarty, 2000), though this remains to be assessed in patients with depression. Here, PDXP is linked to major depressive disorder.